Y15
CAS No. 4506-66-5
Y15( 1245-Benzenetetramine tetrahydrochlor | FAK inhibitor Y15 | FAK Inhibitor 14 )
Catalog No. M20681 CAS No. 4506-66-5
Y15 is a potent and specificsmall-molecule FAK scaffolding inhibitor that inhibits its autophosphorylation activity blocks tumor growth.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 39 | In Stock |
|
| 50MG | 68 | In Stock |
|
| 100MG | 125 | In Stock |
|
| 200MG | 178 | In Stock |
|
| 500MG | 314 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameY15
-
NoteResearch use only, not for human use.
-
Brief DescriptionY15 is a potent and specificsmall-molecule FAK scaffolding inhibitor that inhibits its autophosphorylation activity blocks tumor growth.
-
DescriptionY15 is a potent and specificsmall-molecule FAK scaffolding inhibitor that inhibits its autophosphorylation activity blocks tumor growth.
-
In Vitro——
-
In Vivo——
-
Synonyms1245-Benzenetetramine tetrahydrochlor | FAK inhibitor Y15 | FAK Inhibitor 14
-
PathwayAngiogenesis
-
TargetFAK
-
RecptorFAK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number4506-66-5
-
Formula Weight284.01
-
Molecular FormulaC6H14Cl4N4
-
Purity>98% (HPLC)
-
SolubilityH2O:59 mg/mL (207.74 mM; Need ultrasonic and warming)
-
SMILESCl.Cl.Cl.Cl.Nc1cc(N)c(N)cc1N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.O'Brien S Golubovskaya VM Conroy Jet al.FAK inhibition with small molecule inhibitor Y15 decreases viability clonogenicity and cell attachment in thyroid cancer cell lines and synergizes with targeted therapeutics[J].Oncotarget. 2014 Sep 15;5(17):7945-59.
molnova catalog
related products
-
2119738-71-3
2119738-71-3
-
GSK-2256098
GSK-2256098 (GTPL-7939) is a potent, selective, reversible and ATP-competitive inhibitor of FAK kinase with Ki of 0.4 nM.
-
Conteltinib
CT-707 (Conteltinib) is a novel multikinase inhibitor targeting FAK (IC50=1.6 nM).
Cart
sales@molnova.com